Prior studies have revealed that FERMT1 is overexpressed and acts as a tumor promoter in various cancer types, including breast [38, 39], colon [40], pancreatic [41], and hepatocellular [42] cancer. This evidence concerns the gene FERMT1 and neoplasm.